Essential advances in surgical and adjuvant therapies for colorectal cancer 2018-2019.

作者信息

Akagi Tomonori, Inomata Masafumi

机构信息

Department of Gastroenterological and Pediatric Surgery Faculty of Medicine Oita University Yufu-City Japan.

出版信息

Ann Gastroenterol Surg. 2020 Jan 28;4(1):39-46. doi: 10.1002/ags3.12307. eCollection 2020 Jan.

Abstract

Surgical resection and adjuvant chemotherapy are the only treatment modalities for localized colorectal cancer that can obtain a "cure." The goal in surgically treating primary colorectal cancer is complete tumor removal along with dissection of systematic D3 lymph nodes. Adjuvant treatment controls recurrence and improves the prognosis of patients after they undergo R0 resection. Various clinical studies have promoted the gradual spread and clinical use of new surgical approaches such as laparoscopic surgery, robotic surgery, and transanal total mesorectal excision (TaTME). Additionally, the significance of adjuvant chemotherapy has been established and it is now recommended in the JSCCR (the Japanese Society for Cancer of the Colon and Rectum) guideline as a standard treatment. Herein, we review and summarize current surgical treatment and adjuvant chemotherapy for localized colorectal cancer and discuss recent advances in personalized medicine related to adjuvant chemotherapy.

摘要

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索